Ameritas Investment Partners, Inc. - PROTAGONIST THERAPEUTICS INC ownership

PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 153 filers reported holding PROTAGONIST THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of PROTAGONIST THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$204,851
+19.8%
5,9120.0%0.01%
+16.7%
Q1 2024$171,034
+26.2%
5,9120.0%0.01%
+20.0%
Q4 2023$135,562
+50.9%
5,912
+9.8%
0.01%
+25.0%
Q3 2023$89,838
-27.3%
5,386
+20.3%
0.00%
-20.0%
Q2 2023$123,655
+53.6%
4,477
+27.9%
0.01%
+66.7%
Q1 2023$80,523
+100.5%
3,5010.0%0.00%
+50.0%
Q4 2022$40,156
+38.5%
3,5010.0%0.00%
+100.0%
Q3 2022$29,000
+7.4%
3,5010.0%0.00%0.0%
Q2 2022$27,000
-67.5%
3,5010.0%0.00%
-66.7%
Q1 2022$83,000
-30.8%
3,5010.0%0.00%
-25.0%
Q4 2021$120,000
+110.5%
3,501
+8.0%
0.00%
+100.0%
Q3 2021$57,000
-60.7%
3,2410.0%0.00%
-60.0%
Q2 2021$145,000
+93.3%
3,241
+11.7%
0.01%
+66.7%
Q1 2021$75,000
+44.2%
2,901
+12.4%
0.00%
+50.0%
Q4 2020$52,000
+4.0%
2,5810.0%0.00%0.0%
Q3 2020$50,000
+42.9%
2,581
+29.4%
0.00%0.0%
Q2 2020$35,000
+288.9%
1,995
+49.2%
0.00%
+100.0%
Q1 2020$9,0000.0%1,3370.0%0.00%
Q4 2019$9,000
-43.8%
1,3370.0%0.00%
-100.0%
Q3 2019$16,0000.0%1,3370.0%0.00%0.0%
Q2 2019$16,000
+100.0%
1,337
+37.8%
0.00%
Q1 2018$8,000
-27.3%
970
+88.7%
0.00%
-100.0%
Q4 2017$11,000
+37.5%
5140.0%0.00%
Q3 2017$8,000
+33.3%
5140.0%0.00%
Q2 2017$6,000
-14.3%
5140.0%0.00%
Q1 2017$7,0005140.00%
Other shareholders
PROTAGONIST THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Johnson & Johnson Innovation - JJDC, Inc. 2,449,183$43,253,0008.50%
BVF INC/IL 2,367,288$41,806,0002.58%
RTW INVESTMENTS, LP 3,383,208$59,747,0001.68%
Novo Holdings A/S 824,169$14,555,0000.94%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,013,495$17,898,0000.52%
Sofinnova Investments, Inc. 326,064$5,758,0000.36%
FARALLON CAPITAL MANAGEMENT LLC 2,500,000$44,150,0000.35%
Virtus ETF Advisers LLC 21,639$382,0000.18%
Baker Brothers Advisors 1,911,446$33,756,0000.15%
King Wealth Management Group 22,000$389,0000.11%
View complete list of PROTAGONIST THERAPEUTICS INC shareholders